Myasthenia Gravis Pipeline Landscape Report 2024: Comprehensive Insights About 20+ Companies and 21+ Pipeline Drugs
June 17, 2024 07:05 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Myasthenia Gravis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Myasthenia Gravis (MG) Treatment Industry Forecast to 2030: A $2.5 Billion Market Dominated by Alexion Pharma, Grifols, Avadel Pharma, Novartis, Pfizer, AbbVie, and Roche
April 17, 2024 04:05 ET
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "Myasthenia Gravis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Global Myasthenia Gravis Treatment Market Report 2023: Upsurge in the Number of Pipeline Studies for Drug Development Present Opportunities
March 21, 2023 05:33 ET
|
Research and Markets
Dublin, March 21, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Treatment Market (2023-2028) by Type, End-User, and Geography, Competitive Analysis, Impact of Economic Slowdown &...